Bioequivalence Study of 200 mg Lamotrigine Tablet Under Non-Fasting Conditions

NCT00835263 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Lamotrigine
DRUG: Lamictal®

Sponsor

Teva Pharmaceuticals USA